Raymond James & Associates’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,710
Closed -$19.7K 3910
2023
Q3
$19.7K Sell
14,710
-3,000
-17% -$4.99K ﹤0.01% 3738
2023
Q2
$31.9K Sell
17,710
-3,900
-18% -$6.63K ﹤0.01% 3741
2023
Q1
$35.9K Buy
21,610
+600
+3% +$1.22K ﹤0.01% 3763
2022
Q4
$40.3K Sell
21,010
-350
-2% -$708 ﹤0.01% 3736
2022
Q3
$48K Hold
21,360
﹤0.01% 3710
2022
Q2
$69K Buy
21,360
+5,300
+33% +$23.1K ﹤0.01% 3746
2022
Q1
$84K Buy
16,060
+3,600
+29% +$20.2K ﹤0.01% 3856
2021
Q4
$106K Buy
12,460
+1,000
+9% +$9.19K ﹤0.01% 3852
2021
Q3
$114K Buy
11,460
+500
+5% +$4.53K ﹤0.01% 3809
2021
Q2
$102K Buy
+10,960
New +$125K ﹤0.01% 3833

Other funds holding NUVB